Literature DB >> 26410417

In Vitro Evaluation of ProRoot MTA, Biodentine, and MM-MTA on Human Alveolar Bone Marrow Stem Cells in Terms of Biocompatibility and Mineralization.

Suzan Margunato1, Pakize Neslihan Taşlı2, Safa Aydın2, Meriç Karapınar Kazandağ1, Fikrettin Şahin3.   

Abstract

INTRODUCTION: Stem cell technology has been a great hope for the regeneration of cells of pulp-dentin complex and dental structures together with surrounding bone and periodontium. The main challenge in the regeneration process is a successful combination of stem cells and efficient inductors such as inductive biomaterials. In this regard, today, manufacturers propose novel tooth filling materials. The current study was aimed to compare the effect of ProRoot MTA (Dentsply Tulsa Dental, Tulsa, OK), Biodentine (Septodont, Saint Maur des Fossés, France), and MM-MTA (Micro-Mega, Besançon Cedex, France) on the cell viability, hard tissue deposition capacity, and osteogenic differentiation of human bone marrow stem cells (hBMSCs) derived from mandibular bone.
METHODS: Dental materials were packed into Teflon rings (Grover Corp, Milwaukee, WI) and placed on Transwell inserts (Corning, Corning, NY) to determine the toxicity of tooth filling materials by the 3-(4,5-dimethyl-thiazol-2-yl)-5-(3-carboxy-methoxy-phenyl)-2-(4-sulfo-phenyl)-2H tetrazolium assay on days 1, 3, 7, and 14; 20% dimethyl sulfoxide (DMSO) was used as a positive control for the toxicity assay. hBMSCs were characterized by their surface markers with mesenchymal stem cell antibodies. Teflon rings were cocultured with hBMSCs followed by the induction of osteogenic differentiation. The osteogenic differentiation of hBMSCs and hard tissue formation of the materials were evaluated by analyzing the messenger RNA expression levels of osteonectin, Runt-related transcription factor 2, and collagen type 1A by real-time polymerase chain reaction expression analysis, measurement of alkaline phosphatase activity, and visualization of calcium deposits by alizarin red staining.
RESULTS: MTA, Biodentine, and MM-MTA did not exhibit a cytotoxic effect on hBMSCs after 14 days in culture. Even though all the materials significantly stimulate (P < .05) osteogenic differentiation of hBMSCs compared with the negative control, ProRoot MTA showed greater osteoinductivity than Biodentine or MM-MTA according to the messenger RNA expression, alkaline phosphatase, immunocytochemistry, and alizarin red staining data.
CONCLUSIONS: All of the dental materials used in this study show the osteogenic differentiation potential of hBMSCs. Therefore, newly introduced MM-MTA can also be used as a material of choice in routine dental treatment.
Copyright © 2015 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alveolar bone marrow; Biodentine; MM-MTA; ProRoot MTA; mesenchymal stem cell; osteogenesis

Mesh:

Substances:

Year:  2015        PMID: 26410417     DOI: 10.1016/j.joen.2015.05.012

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  15 in total

1.  How does the pulpal response to Biodentine and ProRoot mineral trioxide aggregate compare in the laboratory and clinic?

Authors:  R Careddu; H F Duncan
Journal:  Br Dent J       Date:  2018-10-19       Impact factor: 1.626

2.  [Effects of mineral trioxide aggregate and ethanolic extracts of Shandong propolis on the biological properties of human dental pulp fibroblasts].

Authors:  B Q Shi; X J Yuan; Y M Zhao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-12-18

Review 3.  In vitro biocompatibility and bioactivity of calcium silicate‑based bioceramics in endodontics (Review).

Authors:  Wencheng Song; Shue Li; Qingming Tang; Lili Chen; Zhenglin Yuan
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

4.  Influence of Biodentine® - A Dentine Substitute - On Collagen Type I Synthesis in Pulp Fibroblasts In Vitro.

Authors:  Frangis Nikfarjam; Kim Beyer; Anke König; Matthias Hofmann; Manuel Butting; Eva Valesky; Stefan Kippenberger; Roland Kaufmann; Detlef Heidemann; August Bernd; Nadja Nicole Zöller
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

5.  Cytotoxicity and Initial Biocompatibility of Endodontic Biomaterials (MTA and Biodentine™) Used as Root-End Filling Materials.

Authors:  Diana María Escobar-García; Eva Aguirre-López; Verónica Méndez-González; Amaury Pozos-Guillén
Journal:  Biomed Res Int       Date:  2016-08-09       Impact factor: 3.411

6.  The Effect of Three Different Biomaterials on Proliferation and Viability of Human Dental Pulp Stem Cells (In-vitro Study).

Authors:  Dalia A Mohamed; Maha I Abdelfattah; Eman H A Aboulezz
Journal:  Open Access Maced J Med Sci       Date:  2017-07-27

7.  The Repair of Furcal Perforations in Different Diameters with Biodentine, MTA, and IRM Repair Materials: A Laboratory Study Using an E. Faecalis Leakage Model.

Authors:  E Övsay; R F Kaptan; F Şahin
Journal:  Biomed Res Int       Date:  2018-01-15       Impact factor: 3.411

8.  Factors affecting the outcomes of direct pulp capping using Biodentine.

Authors:  Mariusz Lipski; Alicja Nowicka; Katarzyna Kot; Lidia Postek-Stefańska; Iwona Wysoczańska-Jankowicz; Lech Borkowski; Paweł Andersz; Anna Jarząbek; Katarzyna Grocholewicz; Ewa Sobolewska; Krzysztof Woźniak; Agnieszka Droździk
Journal:  Clin Oral Investig       Date:  2017-12-12       Impact factor: 3.573

9.  The Response of the Pulp-Dentine Complex, PDL, and Bone to Three Calcium Silicate-Based Cements: A Histological Study in an Animal Rat Model.

Authors:  Ranjdar Mahmood Talabani; Balkees Taha Garib; Reza Masaeli
Journal:  Bioinorg Chem Appl       Date:  2020-04-13       Impact factor: 7.778

10.  Hot air stream reduces cytotoxicity of light-cured calcium hydroxide based cements.

Authors:  Celso-Afonso Klein-Junior; Roberto Zimmer; Diana-Lina-Bronca Borghetti; Fernando-Freitas Portella; Flávia-Carolina Abich; Daniel-Rodrigo Marinowic; Keiichi Hosaka; Eduardo-Galia Reston
Journal:  J Clin Exp Dent       Date:  2020-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.